BMS-986442
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986442, covering 2025-03-18 to 2025-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer [Phase 1, Phase 2]